This illustrates that HMGB1 is able to induce persistent gliosis in young PS19-E4 mice even several weeks post-injection and suggests that the HMGB1 release from hippocampal cells represents a mechanism by which APOE4 promotes gliosis in the context of tauopathy. Here, HMGB1 is linked to tauopathy.